01
Product classification
Identify prescription, Schedule C or C(1), Schedule X, homoeopathic, new-drug, cosmetic or other regulated categories before selecting a route.
Explore this page · jump to a section
PHARMACY • WHOLESALE • DISTRIBUTION • MANUFACTURING
Drug licensing, classified before the application begins.
Match the product, activity, premises, storage system and responsible person to the correct central or state licensing route.
For pharmacies, medical stores, wholesalers, distributors, marketers and manufacturers. The authority, form and evidence depend on the drugs handled and the proposed activity.
01 • APPROACHActivity firstSale or manufacture
02 • AUTHORITYCentral and stateRoute specific
03 • SUPPORTPan IndiaApplication to compliance
Clarity continues beyond the first step.
The original page-specific roadmap is retained here, with every detail available after the quick enquiry panel.
A drug licence is not interchangeable across activities or premises. Retail sale, wholesale distribution, manufacture, Schedule X products, homoeopathic medicines, new drugs, import and test activities can require different permissions and controls.
Compare the licence routes WHAT A DRUG LICENCE AUTHORISES
The pharmacy signboard does not decide the licence. The activity does.
Drug licensing controls who may sell, stock, distribute, manufacture, import or otherwise handle regulated products, from which premises and under whose professional or technical supervision.RegisCorp helps convert the proposed business into the appropriate licence route. We classify the activity and products, assess the authority and premises, test pharmacist or competent-person evidence, prepare the application file and map the conditions that continue after approval.
Plan my drug licence application APPLICATION CONTROLS
Define what will be handled, by whom and at which premises.
02
Business activity
Separate retail sale, wholesale distribution, stocking, exhibition, manufacture, repacking, loan-licence, testing and import activities.
03
Licensing authority
Map State Licensing Authority responsibilities and any Central Licensing Authority permission that applies to the product or activity.
04
Premises readiness
Review area, lawful occupancy, layout, hygiene, access control, refrigeration and other storage arrangements against the proposed scope.
05
Responsible personnel
Confirm the registered pharmacist, competent person or technical staff requirement, qualifications, experience and full-time engagement evidence.
06
Operating compliance
Prepare purchase and sale records, invoices, storage logs, prescription controls, inspection readiness, amendments and renewal or retention actions.
DECISION TABLE
Match the regulated activity to the appropriate permission family.
| Business route | Common permission family | Core readiness test | Important boundary |
|---|---|---|---|
| 01Retail pharmacy | Forms 20 and 21, as applicable | Premises, storage and registered pharmacist | Prescription and schedule-specific sale controls |
| 02Wholesale distribution | Forms 20B and 21B, as applicable | Premises, storage and competent person | Sale to appropriately authorised recipients |
| 03Restricted retail sale | Forms 20A and 21A, where applicable | Eligible restricted product and premises position | No assumption that a full pharmacy activity is authorised |
| 04Schedule X sale | Forms 20F or 20G, as applicable | Enhanced custody, records and authorised personnel | Separate conditions for controlled products |
| 05Homoeopathic medicines | Forms 20C or 20D, as applicable | Product-specific sale route and storage | Not covered merely by an allopathic-drug licence |
| 06Drug manufacture | Manufacturing or loan-licence forms under the relevant product class | Site, technical staff, equipment, testing and GMP | Product approval and site approval are distinct questions |
| 07New drug or clinical route | Permission under the NDCT Rules, 2019 | Product dossier and activity-specific evidence | Central permission may precede or accompany other licensing |
| 08Import or test activity | CDSCO or SUGAM route relevant to the activity | Product, manufacturer, site and intended-use documentation | Commercial import, testing and registration are not the same route |
KEEP THE REGULATORY LAYERS SEPARATE
One pharmaceutical business can need more than one approval.
Retail versus wholesale
A retail licence supports sale to consumers under its conditions; wholesale licensing addresses distribution to authorised trade participants.
Premises versus company
A business entity does not automatically carry one drug licence across every branch, warehouse or operating address.
Licence versus product permission
Authority to operate at a site does not by itself approve a new drug, formulation, claim, manufacturer or imported product.
Pharmacist versus competent person
The responsible-person requirement depends on the activity and licence category; qualifications should be validated before engagement.
State versus central authority
State authorities commonly administer sale and manufacturing licences, while CDSCO handles specified central permissions and functions.
Grant versus continued compliance
Approval remains tied to licence conditions, authorised scope, records, storage, inspection, changes and applicable retention requirements.
DOCUMENT READINESS
Prepare evidence that mirrors the proposed pharmacy or distribution setup.
The final checklist changes with the state, product schedule, business activity, constitution and responsible-person category.Request a tailored checklist- Entity constitution, PAN, incorporation or registration and authorised-signatory documents
- Premises ownership, lease, landlord consent and address evidence
- Site plan, area statement, photographs and local establishment permissions where required
- Registered pharmacist, competent person or technical staff qualification and registration records
- Appointment, experience, identity, attendance and full-time engagement declarations
- Refrigerator, cold-chain, air-conditioning, power backup and storage evidence where applicable
- Product categories, schedules, manufacturers, suppliers and proposed business-activity details
- Existing licences, branch details, amendments, inspection observations and compliance records
OUR WORKFLOW
Classify first. Validate the site. File with a consistent record.
01
Scope map
Record every product class, activity, premises, branch, storage point and supply-chain role.
02
Readiness review
Test the premises, storage system and responsible-person evidence against the selected licence route.
03
Application
Prepare state or central portal information, declarations, attachments and fee submission with consistent particulars.
04
Inspection and control
Support queries or inspection, then monitor conditions, records, personnel changes, premises changes and continuing compliance.
RISK CONTROL
Do not let the licence describe a different business from the one operating.
Incorrect forms, borrowed personnel records, unsuitable premises and unapproved product or address changes can create serious regulatory exposure.- Wrong licence categoryA retail, wholesale, manufacturing, import or special-schedule permission cannot be selected only from the business name.
- Responsible person mismatchQualification, registration, experience and actual engagement should align with the filed and operating position.
- Storage controls not demonstratedTemperature-sensitive and controlled products require evidence that the prescribed conditions can be maintained and recorded.
- Unreported operational changeA branch, premises, constitution, technical person or product-scope change should be checked for prior approval or amendment.
DRUG LICENCE QUESTIONS
Direct answers before a pharmacy or distribution activity starts.
Answers are general guidance. The applicable Act, Rules, product schedule, state procedure, authority directions and facts must be verified for the proposed activity.Ask an expert question01Who needs a drug licence in India?+
A person or entity proposing to sell, stock, exhibit or offer for sale, distribute, manufacture, import or conduct another regulated drug activity should determine the applicable permission before operations begin.
02What is the difference between a retail and wholesale drug licence?+
Retail licensing generally concerns sale to consumers and commonly requires a registered pharmacist. Wholesale licensing concerns distribution to authorised recipients and follows its own competent-person and record conditions.
03Are Forms 20 and 21 always applied for together?+
They commonly cover different product categories and may be paired for a full retail pharmacy, but the correct combination depends on the products and state authority process.
04Does every branch require a separate drug licence?+
Drug licences are premises and activity specific. Each branch, pharmacy or warehouse should be reviewed separately rather than relying on the licence of another location.
05Can an online pharmacy operate with only an ecommerce registration?+
No general ecommerce registration replaces drug-law permissions. The selling entity, licensed premises, supply chain, pharmacist controls and applicable online model must all be assessed.
06Is CDSCO responsible for every drug licence?+
No. State Licensing Authorities administer many sale and manufacturing licences, while CDSCO acts as the Central Licensing Authority for specified functions, products and permissions.
07What happens if the pharmacist or competent person changes?+
The licence holder should check the applicable notification or amendment procedure immediately and must not represent an unavailable person as supervising the activity.
08Can RegisCorp review an existing drug licence setup?+
Yes. The review can compare licences, premises, products, personnel, storage evidence, branches, changes and open inspection or compliance actions.
PRIMARY REFERENCES